Bruhn Suzanne Louise

DirectorVigil Neuroscience, Inc. (VIGL) · full profile →Form 4 · filed Aug 5, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
1 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 5, 2025Disposed to issuer(D)5K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 5, 2025Disposed to issuer(D)14K0
Aug 5, 2025Disposed to issuer(D)24K0
Aug 5, 2025Disposed to issuer(D)6K0
Aug 5, 2025Disposed to issuer(D)24K0
Aug 5, 2025Disposed to issuer(D)18K0
Aug 5, 2025Disposed to issuer(D)34K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-102485) within minutes of acceptance. Every field above traces to the original document. Verify it directly: